Graft-versus-host disease differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 9: Line 9:
The differential diagnosis for GvHD can be categorized into the specific organs involved. When a post-transplant patient develops [[skin]], [[liver]], or [Gastrointestinal tract|GI,]] symptoms, there are numerous possibilities regarding the etiology, as post-transplant patients are immunocompromised and at risk for infections. The clinical manifestations of infection in the [[skin]], [[liver]], or [[Gastrointestinal tract|GI trac]]<nowiki/>t can mimic symptoms of GvHD.
The differential diagnosis for GvHD can be categorized into the specific organs involved. When a post-transplant patient develops [[skin]], [[liver]], or [Gastrointestinal tract|GI,]] symptoms, there are numerous possibilities regarding the etiology, as post-transplant patients are immunocompromised and at risk for infections. The clinical manifestations of infection in the [[skin]], [[liver]], or [[Gastrointestinal tract|GI trac]]<nowiki/>t can mimic symptoms of GvHD.


For [[skin]] signs and symptoms, differential diagnosis includes:
For '''[[skin]]''' signs and symptoms, differential diagnosis includes:


*[[Varicella zoster]] ([[shingles]])
*[[Varicella zoster]] ([[shingles]])
Line 17: Line 17:
*[[Drug eruption]]
*[[Drug eruption]]


For [[liver]] signs and symptoms, differential diagnosis includes:
For '''[[liver]]''' signs and symptoms, differential diagnosis includes:


*[[CMV]] hepatitis<ref name="pmid26729898">{{cite journal| author=McDonald GB| title=How I treat acute graft-versus-host disease of the gastrointestinal tract and the liver. | journal=Blood | year= 2016 | volume= 127 | issue= 12 | pages= 1544-50 | pmid=26729898 | doi=10.1182/blood-2015-10-612747 | pmc=4807421 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26729898  }} </ref>
*[[CMV]] hepatitis<ref name="pmid26729898">{{cite journal| author=McDonald GB| title=How I treat acute graft-versus-host disease of the gastrointestinal tract and the liver. | journal=Blood | year= 2016 | volume= 127 | issue= 12 | pages= 1544-50 | pmid=26729898 | doi=10.1182/blood-2015-10-612747 | pmc=4807421 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26729898  }} </ref>
Line 25: Line 25:
*[[Choledocholithiasis]]
*[[Choledocholithiasis]]


For [[Gastrointestinal tract|gastrointestinal]] signs and symptoms, differential diagnosis includes:
For '''[[Gastrointestinal tract|gastrointestinal]]''' signs and symptoms, differential diagnosis includes:


*[[Typhilitis]] (neutropenic enterocolitis)
*[[Typhilitis]] (neutropenic enterocolitis)

Revision as of 23:57, 4 July 2017

Graft-versus-host disease

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Graft-versus-host disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiograph and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Graft-versus-host disease differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Graft-versus-host disease differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Graft-versus-host disease differential diagnosis

CDC on Graft-versus-host disease differential diagnosis

Graft-versus-host disease differential diagnosis in the news

Blogs on Graft-versus-host disease differential diagnosis

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Graft-versus-host disease differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]

Overview

The differential diagnosis of GvHD is broad given the complexity of post-transplant patients. Infectious etiologies must be considered in persons who under stem cell transplant. A skin rash in the post-transplant setting, for example, could reflect infectious dermatitis or skin GvHD. Liver dysfunction in the post-transplant setting, for example, can reflect an infectious hepatitis of liver GvHD. Gastrointestinal symptoms in the post-transplant setting, for example, could reflect infectious enteritis/colitis or GI GvHD.

Differential Diagnosis

The differential diagnosis for GvHD can be categorized into the specific organs involved. When a post-transplant patient develops skin, liver, or [Gastrointestinal tract|GI,]] symptoms, there are numerous possibilities regarding the etiology, as post-transplant patients are immunocompromised and at risk for infections. The clinical manifestations of infection in the skin, liver, or GI tract can mimic symptoms of GvHD.

For skin signs and symptoms, differential diagnosis includes:

For liver signs and symptoms, differential diagnosis includes:

For gastrointestinal signs and symptoms, differential diagnosis includes:


References

  1. 1.0 1.1 1.2 McDonald GB (2016). "How I treat acute graft-versus-host disease of the gastrointestinal tract and the liver". Blood. 127 (12): 1544–50. doi:10.1182/blood-2015-10-612747. PMC 4807421. PMID 26729898.

Template:WS Template:WH